The chest CT scan revealed a mass on the left upper lobule of the lung with left pleural effusion
胸部CT示:左上肺肿块,左侧胸腔积液The chest CT scan revealed a mass on the left upper lobule of the lung with left pleural effusion入院查体:营养中等,双锁骨上可及多发肿大淋巴结,最大直径约2 cm,质硬、边界清、无压痛、活动差。胸廓对称,左下肺叩浊,呼吸音低,双肺未闻及干湿性啰音。心律齐,各瓣膜区未闻及杂音。腹软,无压痛,肝脾未及,双下肢无水肿,无杵状指。入院后诊治经过:血尿便常规、肝肾功能和电解质均正常;癌胚抗原、神经原烯醇化酶和细胞角蛋白19片断略高于正常。血脂:总胆固醇TC 5.16 mmol/L(正常范围3.59 mmol/L-5.17 mmol/L),甘油三酯TG 1.73 mmol/L(正常范围0.57 mmol/L-1.71 mmol/L),高密度脂蛋白HDL 0.96 mmol/L(正常范围0.8 mmol/L-2.2 mmol/L),低密度脂蛋白LDL 3.41 mmol/L(正常范围1.33 mmol/L-3.36 mmol/L)。于入院当天行胸腔穿刺置管引流术,为白色混浊乳糜样胸水(图 2),比重1.038,粘蛋白定性试验3+,有核细胞1.0×109/L,中性粒细胞:32%,淋巴细胞:68%,总蛋白86 g/L,腺苷脱氢酶ADA 8.3 U/L,乳酸脱氢酶LDH 212 U/L,胸水TC 3.52 mmol/L,TG 28.58 mmol/L,革兰氏及抗酸染色均阴性,胸水未见肿瘤细胞。支气管镜检查:左上叶升支尖后段开口狭窄,间嵴增宽,病理显示为粘膜慢性炎症。B超示:双侧腋下和颈部、双侧锁骨上及腹股沟区多发淋巴结肿大。PET-CT检查(图 3)示:左肺上叶软组织肿块影,代谢异常增高,考虑为恶性病变伴颈、胸部多发淋巴结、左侧胸膜及双肺转移。左锁骨上淋巴结活检病理示:转移性低分化腺癌(图 4);免疫组化示:癌细胞呈CK7、TTF-1弥漫性阳性,34βE12散在少许阳性,P63阴性。综合上述检查结果,考虑为左侧低分化肺腺癌伴发乳糜胸。治疗上充分引流胸腔积液后予生理盐水20 mL+香菇多糖2 mg胸膜腔内注射。家属拒绝化疗,接受吉非替尼单药治疗,1周后患者自觉憋气缓解,食欲改善,乏力状况有所改善而出院。
2
白色乳糜样胸腔积液
White chylous pleural effusion sample
3
PET-CT示:纵隔内多发大小不等淋巴结,代谢异常增高,左肺上叶软组织肿块影,代谢异常增高
PET-CT scan revealed the enlargement of mediastinal lymph nodes was in multiple sizes, with higher uptake of FDG. The mass on the left upper lobule of the lung also showed higher uptake of FDG
4
左锁骨上淋巴结活检病理:转移性低分化腺癌(HE, ×100)
The left supraclavicular lymph node biopsy demonstrated metastatic poorly differentiated adenocarcinoma (HE, ×100)
白色乳糜样胸腔积液White chylous pleural effusion samplePET-CT示:纵隔内多发大小不等淋巴结,代谢异常增高,左肺上叶软组织肿块影,代谢异常增高PET-CT scan revealed the enlargement of mediastinal lymph nodes was in multiple sizes, with higher uptake of FDG. The mass on the left upper lobule of the lung also showed higher uptake of FDG左锁骨上淋巴结活检病理:转移性低分化腺癌(HE, ×100)The left supraclavicular lymph node biopsy demonstrated metastatic poorly differentiated adenocarcinoma (HE, ×100)
Authors: Fabien Maldonado; Finn J Hawkins; Craig E Daniels; Clinton H Doerr; Paul A Decker; Jay H Ryu Journal: Mayo Clin Proc Date: 2009-02 Impact factor: 7.616